Trial Profile
Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2011
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- Acronyms STARS-II
- Sponsors AstraZeneca
- 17 Aug 2011 Health-related QOL results published in the Alimentary Pharmacology and Therapeutics.
- 05 Nov 2010 New trial record.